首页 > 最新文献

PharmacoEconomics & Outcomes News最新文献

英文 中文
Ranibizumab, aflibercept not cost effective for polypoidal choroidal vasculopathy in Thailand 在泰国，雷尼单抗、阿非利西普治疗息肉样脉络膜血管病变不具有成本效益
PharmacoEconomics & Outcomes News
Pub Date : 2021-11-01 DOI: 10.1007/s40274-021-08215-z
{"title":"Ranibizumab, aflibercept not cost effective for polypoidal choroidal vasculopathy in Thailand","authors":"","doi":"10.1007/s40274-021-08215-z","DOIUrl":"https://doi.org/10.1007/s40274-021-08215-z","url":null,"abstract":"","PeriodicalId":19781,"journal":{"name":"PharmacoEconomics & Outcomes News","volume":"89 1","pages":"20 - 20"},"PeriodicalIF":0.0,"publicationDate":"2021-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"80216547","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
NICE draft guidance recommends dapagliflozin for some patients with chronic kidney disease NICE指南草案推荐达格列净用于一些慢性肾病患者
PharmacoEconomics & Outcomes News
Pub Date : 2021-11-01 DOI: 10.1007/s40274-021-08191-6
Meindert Boysen
{"title":"NICE draft guidance recommends dapagliflozin for some patients with chronic kidney disease","authors":"Meindert Boysen","doi":"10.1007/s40274-021-08191-6","DOIUrl":"https://doi.org/10.1007/s40274-021-08191-6","url":null,"abstract":"","PeriodicalId":19781,"journal":{"name":"PharmacoEconomics & Outcomes News","volume":"36 1","pages":"33 - 33"},"PeriodicalIF":0.0,"publicationDate":"2021-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"81157088","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Costs high after triple drug class therapy for multiple melanoma 多发性黑色素瘤三联药物治疗后费用高
PharmacoEconomics & Outcomes News
Pub Date : 2021-11-01 DOI: 10.1007/s40274-021-08164-9
{"title":"Costs high after triple drug class therapy for multiple melanoma","authors":"","doi":"10.1007/s40274-021-08164-9","DOIUrl":"https://doi.org/10.1007/s40274-021-08164-9","url":null,"abstract":"","PeriodicalId":19781,"journal":{"name":"PharmacoEconomics & Outcomes News","volume":"85 1","pages":"6 - 6"},"PeriodicalIF":0.0,"publicationDate":"2021-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"83907291","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Counting the cost of rotavirus hospitalisation among young children in Bangladesh 计算孟加拉国幼儿因轮状病毒住院治疗的费用
PharmacoEconomics & Outcomes News
Pub Date : 2021-11-01 DOI: 10.1007/s40274-021-08208-0
{"title":"Counting the cost of rotavirus hospitalisation among young children in Bangladesh","authors":"","doi":"10.1007/s40274-021-08208-0","DOIUrl":"https://doi.org/10.1007/s40274-021-08208-0","url":null,"abstract":"","PeriodicalId":19781,"journal":{"name":"PharmacoEconomics & Outcomes News","volume":"16 1","pages":"13 - 13"},"PeriodicalIF":0.0,"publicationDate":"2021-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"84377872","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Rivaroxaban reduces HRU, costs vs warfarin for AF in US patients with obesity and diabetes 与华法林相比，利伐沙班降低了美国肥胖和糖尿病患者房颤的HRU和成本
PharmacoEconomics & Outcomes News
Pub Date : 2021-11-01 DOI: 10.1007/s40274-021-08182-7
{"title":"Rivaroxaban reduces HRU, costs vs warfarin for AF in US patients with obesity and diabetes","authors":"","doi":"10.1007/s40274-021-08182-7","DOIUrl":"https://doi.org/10.1007/s40274-021-08182-7","url":null,"abstract":"","PeriodicalId":19781,"journal":{"name":"PharmacoEconomics & Outcomes News","volume":"12 1","pages":"24 - 24"},"PeriodicalIF":0.0,"publicationDate":"2021-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"89895648","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Active TB screening may be cost saving in high-incidence Inuit communities in Canada 主动结核病筛查可能在加拿大因纽特人的高发病率社区节省费用
PharmacoEconomics & Outcomes News
Pub Date : 2021-11-01 DOI: 10.1007/s40274-021-08159-x
{"title":"Active TB screening may be cost saving in high-incidence Inuit communities in Canada","authors":"","doi":"10.1007/s40274-021-08159-x","DOIUrl":"https://doi.org/10.1007/s40274-021-08159-x","url":null,"abstract":"","PeriodicalId":19781,"journal":{"name":"PharmacoEconomics & Outcomes News","volume":"138 1","pages":"1 - 1"},"PeriodicalIF":0.0,"publicationDate":"2021-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"75640683","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Cancer care in the USA presents substantial economic burden for patients 在美国，癌症治疗给患者带来了巨大的经济负担
PharmacoEconomics & Outcomes News
Pub Date : 2021-11-01 DOI: 10.1007/s40274-021-08162-9
Y. Shih
{"title":"Cancer care in the USA presents substantial economic burden for patients","authors":"Y. Shih","doi":"10.1007/s40274-021-08162-9","DOIUrl":"https://doi.org/10.1007/s40274-021-08162-9","url":null,"abstract":"","PeriodicalId":19781,"journal":{"name":"PharmacoEconomics & Outcomes News","volume":"8 1","pages":"4 - 4"},"PeriodicalIF":0.0,"publicationDate":"2021-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"83113093","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Treating major depressive disorder reduces costs of comorbid conditions 治疗重度抑郁症可降低合并症的费用
PharmacoEconomics & Outcomes News
Pub Date : 2021-11-01 DOI: 10.1007/s40274-021-08220-y
{"title":"Treating major depressive disorder reduces costs of comorbid conditions","authors":"","doi":"10.1007/s40274-021-08220-y","DOIUrl":"https://doi.org/10.1007/s40274-021-08220-y","url":null,"abstract":"","PeriodicalId":19781,"journal":{"name":"PharmacoEconomics & Outcomes News","volume":"12 1","pages":"25 - 25"},"PeriodicalIF":0.0,"publicationDate":"2021-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"90294924","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
NZ's Pharmac transitions to biosimilar adalimumab, Amgevita, to widen access 新西兰制药公司过渡到阿达木单抗生物仿制药Amgevita，以扩大准入
PharmacoEconomics & Outcomes News
Pub Date : 2021-11-01 DOI: 10.1007/s40274-021-08230-x
{"title":"NZ's Pharmac transitions to biosimilar adalimumab, Amgevita, to widen access","authors":"","doi":"10.1007/s40274-021-08230-x","DOIUrl":"https://doi.org/10.1007/s40274-021-08230-x","url":null,"abstract":"","PeriodicalId":19781,"journal":{"name":"PharmacoEconomics & Outcomes News","volume":"28 1","pages":"35 - 35"},"PeriodicalIF":0.0,"publicationDate":"2021-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"88843333","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Universal HBV vaccination programme with antenatal HBsAg screening cost saving in Israel 在以色列普及乙肝疫苗接种计划和产前乙肝表面抗原筛查节省了费用
PharmacoEconomics & Outcomes News
Pub Date : 2021-11-01 DOI: 10.1007/s40274-021-08223-y
{"title":"Universal HBV vaccination programme with antenatal HBsAg screening cost saving in Israel","authors":"","doi":"10.1007/s40274-021-08223-y","DOIUrl":"https://doi.org/10.1007/s40274-021-08223-y","url":null,"abstract":"","PeriodicalId":19781,"journal":{"name":"PharmacoEconomics & Outcomes News","volume":"18 1","pages":"28 - 28"},"PeriodicalIF":0.0,"publicationDate":"2021-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"85279679","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
首页 上一页 下一页 尾页
类型
全部 化学•材料 生命科学 医学 物理 工程技术 环境•农林 材料科学 地球科学 法学 管理学 化学 环境科学与生态学 计算机科学 教育学 经济学 农林科学 人文科学 生物学 数学 物理与天体物理 心理学 综合性期刊 其他 工业工程 理学 历史学 农学 文学 信息工程
数据库
全部 ACS Publications Elsevier ieeexplore Springer The Royal Society of Chemistry Wiley
期刊
PharmacoEconomics & Outcomes News
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
﹀
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整，为了账户安全，请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号：481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们：info@booksci.cn
Book学术提供免费学术资源搜索服务，方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1